Mirae Asset Global ETFs Holdings
VKTX icon

Mirae Asset Global ETFs Holdings’s Viking Therapeutics VKTX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$267K Sell
8,937
-143
-2% -$4.6K ﹤0.01% 2198
2025
Q4 		$321K Sell
9,080
-1,115
-11% -$39.5K ﹤0.01% 2121
2025
Q3 		$263K Buy
10,195
+2,502
+33% +$74.6K ﹤0.01% 2183
2025
Q2 		$204K Sell
7,693
-863
-10% -$22.7K ﹤0.01% 2273
2025
Q1 		$219K Sell
8,556
-2,241
-21% -$70.8K ﹤0.01% 2278
2024
Q4 		$429K Buy
+10,797
New +$616K ﹤0.01% 1997
2024
Q3 		– Sell
-64,820
Closed -$3.41M – 3189
2024
Q2 		$3.41M Buy
+64,820
New +$4.25M 0.01% 881

Other funds holding VKTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's VKTX Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Viking Therapeutics (VKTX) stake by 1.6% in Q1 2026, selling an estimated $4.6K and leaving 8,937 shares worth $267K. The position accounts for ﹤0.01% of the portfolio, ranked #2198.

Mirae Asset Global ETFs Holdings first reported a position in VKTX in Q2 2024 and has held it in 7 quarters since. The position peaked at $3.41M in Q2 2024. 410 funds tracked by Wall St. Rank hold VKTX as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 8,937 shares of Viking Therapeutics worth $267K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings sold 143 Viking Therapeutics shares in Q1 2026, an estimated $4.6K.
  • Viking Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2198 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Viking Therapeutics in Q2 2024 and has held it in 7 quarters since.
  • Mirae Asset Global ETFs Holdings's Viking Therapeutics position peaked at $3.41M in Q2 2024.
  • 410 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.